Immunization of dogs with a DNA vaccine induces protection against rabies virus

Vaccine

Volumn 18, Issue 5-6, 1999, Pages 479-486

  Perrin, P ^a   Jacob, Y ^a   Aguilar Setien A ^b   Loza Rubio, E ^c   Jallet, C ^a   Desmezieres E ^a   Aubert, M ^d   Cliquet, F ^d   Tordo, N ^a  

^a INSTITUT PASTEUR   (France)

^b U de Invest Medica en Immunol   (Mexico)

^c INSTITUTO NACIONAL DE INVESTIGACIONES FORESTALES   (Mexico)

^d Healthy Pigs Production and Experimentation Section   (France)

Author keywords

DNA immunization; Dog; Lyssavirus; Rabies; Vaccine

Indexed keywords

DNA VACCINE; GLYCOPROTEIN; NEUTRALIZING ANTIBODY;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; RABIES; RABIES VIRUS;

ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; DOGS; FEMALE; IMMUNIZATION; LYSSAVIRUS; MALE; RABIES VACCINES; VACCINES, DNA;

EID: 0032825504     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00247-9     Document Type: Article

References (25)

1. Amengal B., Whitby J., Cobo S., Bourhy H. Evolution of european bat lyssaviruses. J Gen Virol. 78:1997;2319-2328.
2. Aubert M.F.A. Can vaccination validated by the titration of rabies antibodies in serum of cats and dogs be an alternative to quarantine measures? Abstract of Hygiene and Communicable Diseases. 68:1993;R1-R22.
3. Babiuk L., Lewis P., Drunen S., Tikoo S., Liang X. Nucleic acid vaccines: veterinary applications. Compans R.W., et al. Current topics microbio-logy and immunology. vol. 226:1998;90 Springer-Verlag, Berlin.
4. Bahloul C., Jacob Y., Tordo N., Perrin P. DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine. 16:1998;417-425.
5. Blancou J., Aubert M.F.A., Soulebot J.P. Difference dans le pouvoir pathogène de souches de virus rabiques adaptées au renard et au chien. Ann Virol. 134E:1983;523-531.
6. Blancou J., Aubert M.F.A. Transmission of the rabies virus: importance of the species barrier. Bull Acad Natl Med. 181:1997;301-312.
7. Dreesen D. A global review of rabies vaccines for human use. Vaccine. 15:1997;S2-S6.
8. Gould A., Hyatt A., Lunt R., Kattenbelt J., Hengstberger S., Blacksell S. Characterisation of a novel lyssavirus isolated from Pteroid bats in Australia. Virus Research. 54:1998;165-187.
9. Jallet C., Jacob Y., Bahloul C., Drings A., Desmézières E., Tordo N., Perrin P. Chimeric lyssavirus glycoproteins with increased immunological potential. J Virol. 73:1999;225-233.
10. Jiang W., Baker H., Swango L., Schorr J., Self M., Smith B. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus. Vaccine. 16:1998;601-607.
11. Lodmell D., Ray N., Ewalt R., Hanlon D., Shaddock J., Sanderlin D., Rupprecht C. Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection. Vaccine. 16:1998;115-118.
12. Lodmell D., Ray N., Parnell M., Ewalt R., Hanlon D., Shaddock J., Sanderlin D., Rupprecht C. DNA immunization protects nonhuman primates against rabies virus. Nature Med. 4:1998;949-952.
13. Meslin F.-X., Fishbein D., Matter H. Rationale and prospects for rabies elimination in developing countries. Rupprecht, et al. Lyssaviruses. 1994;1 Springer-Verlag, Berlin.
14. OIE. Rabies in Denmark in sheep. Disease information 1998;11(34).
15. OIE. Rabies in Denmark. Disease information 1998;11(37).
16. Pastoret P.-P., Brochier B., Aguilar-Setién A., Blancou J. Vaccination against rabies. Pastoret P.-P., et al. Veterinary vaccinology. 1997;616 Elsevier, Amsterdam.
17. Perrin P., Versmisse P., Delagneau J.F., Lucas G., Rollin P., Sureau P. The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus. J Biol Standard. 14:1986;95-102.
18. Perrin P., Madhusudana S., Jallet C., Petres S., Tordo N., Merten O-W. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion system. Vaccine. 13:1995;1244-1250.
19. Perrin P., De Franco M., Jallet C., Fouque F., Morgeaux S., Tordo N., Colle J.-H. The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses. Res. Virol. 147:1996;289-299.
20. Perrin P. Techniques for the preparation of rabies conjugates. Meslin F.-X., Kaplan M., Koprowski H. Laboratory techniques in rabies. 4th ed :1996;433 WHO, Geneva.
21. Sato M., Maeda N., Yoshida H., Urade M., Saito S., Miyazaki T., Shibata T., Watanabe M. Plaque formation of herpes virus Hominis type 2 and rubella virus in variants isolated from the colonies of BHK-21/WI-2 cells formed in soft agar. Arch Virol. 53:1977;269-273.
22. Smith J., Yager P., Baer G. A rapid fluorescent focus inhibition test (RFFIT) for determining virus-neutralizing antibody. Meslin F.-X., Kaplan M., Koprowski H. Laboratory techniques in rabies. 4th ed :1996;181 WHO, Geneva.
23. Theodorides J. Histoire de la rage. 1986;17 Masson, Paris.
24. WHO. World Survey of Rabies. World Health Organization, Geneva 1994; 210.
25. Xiang Z., Spitalnik S., Tran M., Wunner W., Cheng J., Ertl H. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virol. 199:1994;132-140.